Idexx Laboratories, Inc. | Large-cap | Healthcare
$542.71
0.01%
| Idexx Laboratories Stock Comparison:
Idexx Laboratories vs Thermo FisherIdexx Laboratories vs DanaherIdexx Laboratories vs Agilent TechnologiesIdexx Laboratories vs Iqvia HoldingsIdexx Laboratories vs Mettler-ToledoIdexx Laboratories vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 3.9B
Gross Profit 2.4B 61.04%
Operating Income 1.1B 28.95%
Net Income 887.9M 22.78%
EPS (Diluted) $10.67

Balance Sheet Metrics

Total Assets 3.3B
Total Liabilities 1.7B
Shareholders Equity 1.6B
Debt to Equity 1.06

Cash Flow Metrics

Operating Cash Flow 921.9M
Free Cash Flow 798.1M

Revenue & Profitability Trend

Idexx Laboratories Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 3.9B 3.7B 3.4B 3.2B 2.7B
Cost of Goods Sold 1.5B 1.5B 1.4B 1.3B 1.1B
Gross Profit 2.4B 2.2B 2.0B 1.9B 1.6B
Operating Expenses 1.3B 1.1B 1.1B 957.4M 876.5M
Operating Income 1.1B 1.1B 898.8M 932.0M 694.5M
Pre-tax Income 1.1B 1.1B 860.0M 902.7M 662.0M
Income Tax 222.0M 216.1M 180.9M 157.8M 79.9M
Net Income 887.9M 845.0M 679.1M 744.8M 582.1M
EPS (Diluted) $10.67 $10.06 $8.03 $8.60 $6.71

Income Statement Trend

Idexx Laboratories Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 1.4B 1.5B 1.1B 955.7M 1.1B
Non-Current Assets 1.9B 1.8B 1.6B 1.5B 1.2B
Total Assets 3.3B 3.3B 2.7B 2.4B 2.3B
Liabilities
Current Liabilities 1.1B 951.5M 1.2B 763.6M 582.8M
Non-Current Liabilities 630.2M 823.8M 902.2M 983.6M 1.1B
Total Liabilities 1.7B 1.8B 2.1B 1.7B 1.7B
Equity
Total Shareholders Equity 1.6B 1.5B 608.7M 690.0M 632.8M

Balance Sheet Composition

Idexx Laboratories Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 887.9M 845.0M 679.1M 744.8M 582.1M
Operating Cash Flow 921.9M 899.5M 534.8M 748.9M 640.6M
Investing Activities
Capital Expenditures -120.9M -133.6M -148.8M -119.5M -107.0M
Investing Cash Flow -197.1M -125.3M -185.4M -293.0M -108.5M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow -922.6M -489.0M -406.7M -744.0M -299.7M
Free Cash Flow 798.1M 772.9M 384.1M 636.0M 540.2M

Cash Flow Trend

Idexx Laboratories Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 48.33
Forward P/E 43.81
Price to Book 29.21
Price to Sales 10.72
PEG Ratio 43.81

Profitability Ratios

Profit Margin 22.76%
Operating Margin 31.70%
Return on Equity 59.33%
Return on Assets 22.98%

Financial Health

Current Ratio 1.16
Debt to Equity 73.16
Beta 1.55

Per Share Data

EPS (TTM) $10.84
Book Value per Share $17.93
Revenue per Share $47.94

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
idxx 42.1B 48.33 29.21 59.33% 22.76% 73.16
Thermo Fisher 152.5B 23.69 3.09 13.70% 15.19% 69.23
Danaher 140.5B 37.98 2.76 7.22% 15.81% 34.56
Agilent Technologies 33.0B 28.60 5.37 18.88% 17.59% 60.04
Iqvia Holdings 27.4B 21.64 4.61 21.64% 8.61% 242.91
Mettler-Toledo 24.0B 28.82 -135.91 -680.23% 22.17% -11.40

Financial data is updated regularly. All figures are in the company's reporting currency.